Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies.
about
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsHPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study.Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing.Cost and logistics of alternative roll-out options for implementing human papillomavirus testing as a triage in cervical screening: results of the sentinel sites study.Public awareness of human papillomavirus.Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study.Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate.ABC3 Part I: a review of the guidelines for terminology, classification and management of cervical cytology in England.Cervical cancer screening among HIV-infected women: an economic evaluation in a middle-income country.Economic evaluation of strategies for managing women with equivocal cytological results in Brazil.Incidence of cervical intraepithelial neoplasia grade 2 or worse in colposcopy-negative/human papillomavirus-positive women with low-grade cytological abnormalities.Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis.Comparison of the performance of HPV tests in women with abnormal cytology: results of a study within the NHS cervical screening programme.Human papillomavirus testing in young women: clinical outcomes of human papillomavirus triage in a UK cervical screening program.When to test women for human papillomavirus.When to test women for human papillomavirus: take this opportunity to screen for anal cancer too.Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.
P2860
Q24198236-C8609658-C9E0-465E-BC48-B3D9584162E7Q35262983-A9EA878C-5C6C-4569-AF02-7118861E0006Q36371450-90CC6917-11EE-4BEA-AD92-B4D6FBEE95D5Q36385319-62C61BD7-4326-4CC4-8AEE-394662B3758AQ36705407-B752DBC0-A394-4324-9A8F-6096C633EF09Q37281725-B8816E9C-65A8-48F7-8962-A4AF668C300DQ37294687-62CB091B-2F8F-46AC-9D11-B221F695C323Q38061688-430C5382-AF05-4AAC-979D-51145E54D605Q39553755-959D5298-B6FB-4414-B7A6-70C3599B26C1Q39553769-9EBBC1FF-D5FA-4085-A2ED-A39FCDA38927Q39744848-C52563F3-F725-4662-AC73-9E760CB288AEQ40226939-4255AEA9-C1E2-4382-83B2-F1A19790C87FQ41719545-D95B383A-EFBA-49D2-9089-9F547CD3E8C4Q42215194-5422A660-18F4-4FFC-AFD5-CC55A72BC81BQ43154659-36FAD667-8A97-4E5C-A19A-C29BA0B2B150Q43186845-66D5E4E5-1734-4413-BC68-16545E06A091Q44779725-AA3B49A9-C31C-4CF5-94DF-C73D5C0E7571Q51165744-1AEC6335-732D-458E-A459-2FCCE9BED6C4
P2860
Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Lifetime effects, costs, and c ...... ults of the NHS pilot studies.
@ast
Lifetime effects, costs, and c ...... ults of the NHS pilot studies.
@en
Lifetime effects, costs, and c ...... ults of the NHS pilot studies.
@nl
type
label
Lifetime effects, costs, and c ...... ults of the NHS pilot studies.
@ast
Lifetime effects, costs, and c ...... ults of the NHS pilot studies.
@en
Lifetime effects, costs, and c ...... ults of the NHS pilot studies.
@nl
prefLabel
Lifetime effects, costs, and c ...... ults of the NHS pilot studies.
@ast
Lifetime effects, costs, and c ...... ults of the NHS pilot studies.
@en
Lifetime effects, costs, and c ...... ults of the NHS pilot studies.
@nl
P2093
P2860
P1433
P1476
Lifetime effects, costs, and c ...... ults of the NHS pilot studies.
@en
P2093
Alastair Gray
Jane Wolstenholme
Rosa Legood
P2860
P356
10.1136/BMJ.38698.458866.7C
P407
P577
2006-01-06T00:00:00Z